Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)
Clinical trial NCT05904054 · COMPLETED
Trial details
- NCT number
- NCT05904054
- Sponsor
- Immuno Cure 3 Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-15
- Primary completion
- 2023-12-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.